Q&A: FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer’s Drug Approval
Similar Posts
Mount Sinai Adds Chief Data Officer Role
Renown biomedical data expert, Dr. Andrew Kasarskis, aims to accelerate data-driven discovery and patient care Andrew Kasarskis, PhD, an…
Alzheimer’s Research & Therapy:
Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based TestStudy published in peer-reviewed journal demonstrates superior sensitivity and accuracy of Linus Health’s digital cognitive assessment over the…
Windham Venture Partners Hires Successful Healthcare Investor, David Kereiakes, And Expands Presence in the Midwest
Windham Venture Partners Expands to Midwest and Welcomes David Kereiakes as Managing Partner Windham Venture Partners, a healthtech venture…
